Royalty Pharma RPRX Stock
$69.32
-0.985577%
Add to favorites
SECTOR
INDUSTRY
COUNTRY
Exchange
Market Cap
$39.86B
LOW - HIGH [24H]
$69.13
-
$70.37
VOLUME [24H]
$1.94M
P/E Ratio
45.30
Earnings per share
$1.53
ISIN
GB00BMVP7Y09
Royalty Pharma Price Chart
Royalty Pharma RPRX Financial and Trading Overview
| Royalty Pharma stock price | 69.32 USD |
| Previous Close | 68.77 USD |
| Open | 68.26 USD |
| Bid | 63.17 USD x 200 |
| Ask | 73.25 USD x 200 |
| Day's Range | 67.73 - 69.59 USD |
| 52 Week Range | 37.31 - 69.77 USD |
| Volume | 3.42M USD |
| Avg. Volume | 3.12M USD |
| Market Cap | 39.93B USD |
| Beta (5Y Monthly) | 0.358 |
| PE Ratio (TTM) | 45.392155 |
| EPS (TTM) | 1.53 USD |
| Forward Dividend & Yield | 0.94 (1.35%) |
| Ex-Dividend Date | November 13, 2026 |
| 1y Target Est | 72 USD |
RPRX Valuation Measures
| Enterprise Value | 41.92B USD |
| Trailing P/E | 45.392155 |
| Forward P/E | 11.748604 |
| PEG Ratio (5 yr expected) | 2.09 |
| Price/Sales (ttm) | 15.260197 |
| Price/Book (mrq) | 4.5285597 |
| Enterprise Value/Revenue | 16.021 |
| Enterprise Value/EBITDA | 24.801 |
Trading Information
Royalty Pharma Stock Price History
| Beta (5Y Monthly) | 0.358 |
| 52-Week Change | 76.51% |
| S&P500 52-Week Change | 9.84% |
| 52 Week High | 69.77 USD |
| 52 Week Low | 37.31 USD |
| 50-Day Moving Average | 60.97 USD |
| 200-Day Moving Average | 54.05 USD |
RPRX Share Statistics
| Avg. Volume (3 month) | 3.12M USD |
| Avg. Daily Volume (10-Days) | 3.55M USD |
| Shares Outstanding | 445.27M |
| Float | 417.1M |
| Short Ratio | 4.05 |
| % Held by Insiders | 6.49% |
| % Held by Institutions | 88.22% |
| Shares Short | 13.08M |
| Short % of Float | 2.97% |
| Short % of Shares Outstanding | 2.93% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.925 |
| Trailing Annual Dividend Yield | 1.34% |
| 5 Year Average Dividend Yield | 216.00% |
| Payout Ratio | 0.6046 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | September 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 25.69% |
| Operating Margin (ttm) | 81.32% |
| Gross Margin | 99.78% |
| EBITDA Margin | 64.59% |
Management Effectiveness
| Return on Assets (ttm) | 5.42% |
| Return on Equity (ttm) | 12.08% |
Income Statement
| Revenue (ttm) | 2.62B USD |
| Revenue Per Share (ttm) | 5.96 USD |
| Quarterly Revenue Growth (yoy) | 13.30% |
| Gross Profit (ttm) | 2.61B USD |
| EBITDA | 1.69B USD |
| Net Income Avi to Common (ttm) | 672.45M USD |
| Diluted EPS (ttm) | 1.53 |
| Quarterly Earnings Growth (yoy) | -49.10% |
Balance Sheet
| Total Cash (mrq) | 544.86M USD |
| Total Cash Per Share (mrq) | 1.22 USD |
| Total Debt (mrq) | 8.59B USD |
| Total Debt/Equity (mrq) | 87.67 USD |
| Current Ratio (mrq) | 1.294 |
| Book Value Per Share (mrq) | 15.336 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 2.96B USD |
| Levered Free Cash Flow (ttm) | -450273632 USD |
Profile of Royalty Pharma
| Country | United States |
| State | NY |
| City | New York |
| Address | 110 East 59th Street |
| ZIP | 10022 |
| Phone | 212 883 0200 |
| Website | https://www.royaltypharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 100 |
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of JNJ-4804, an investigational medicine for autoimmune diseases. The company was founded in 1996 and is based in New York, New York.
Q&A For Royalty Pharma Stock
What is a current RPRX stock price?
Royalty Pharma RPRX stock price today per share is 69.32 USD.
How to purchase Royalty Pharma stock?
You can buy RPRX shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Royalty Pharma?
The stock symbol or ticker of Royalty Pharma is RPRX.
Which industry does the Royalty Pharma company belong to?
The Royalty Pharma industry is Biotechnology.
How many shares does Royalty Pharma have in circulation?
The max supply of Royalty Pharma shares is 574.99M.
What is Royalty Pharma Price to Earnings Ratio (PE Ratio)?
Royalty Pharma PE Ratio is 45.30719000 now.
What was Royalty Pharma earnings per share over the trailing 12 months (TTM)?
Royalty Pharma EPS is 1.53 USD over the trailing 12 months.
Which sector does the Royalty Pharma company belong to?
The Royalty Pharma sector is Healthcare.
Royalty Pharma RPRX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
|
- | |||||
US Tech Composite
IXIC
US
|
25410.97 USD — |
-0.22
|
6.22B USD — | 25068.28 USD — | 25597.23 USD — | — - | 6.22B USD — |
|
US Tech Composite Total Return
XCMP
US
|
31386.02 USD — |
-0.25
|
— — | 30976.16 USD — | 31629.69 USD — | — - | — — |
|
US Tech Q-50
NXTQ
US
|
1232.41 USD — |
-1.17
|
— — | 1227.36 USD — | 1243.64 USD — | — - | — — |
|
US Tech Next Generation 100 Inde
NGX
US
|
1774.56 USD — |
-1.08
|
— — | 1768.07 USD — | 1788.89 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
7299.08 USD — |
-1.61
|
— — | 7259.36 USD — | 7373.62 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1381.51 USD — |
-1.38
|
— — | 1374.27 USD — | 1394.6 USD — | — - | — — |
|
Horizon Kinetics ISE Wealth Ind
RCH
US
|
4189.11 USD — |
-0.06
|
— — | 4162.92 USD — | 4194.53 USD — | — - | — — |
|
US Tech Global Select Market Com
NQGS
US
|
12507.14 USD — |
-0.23
|
— — | 12339.28 USD — | 12603.6 USD — | — - | — — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
4000.62 USD — |
-1.26
|
— — | 3927.42 USD — | 4148.65 USD — | — - | — — |
